|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ju JA, Huang YC, Lan SH, Wang TH, Lin PC,
Lee JC, Niu KC, Tian YF and Liu HS: Identification of colorectal
cancer recurrence-related microRNAs. Gen Med Biomark Health Sci.
4:19–20. 2012.
|
|
8
|
Blenkiron C and Miska EA: miRNAs in
cancer: Approaches, aetiology, diagnostics and therapy. Hum Mol
Genet. 16:R106–R113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bommer GT, Gerin I, Feng Y, Kaczorowski
AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al:
p53-mediated activation of miRNA34 candidate tumor-suppressor
genes. Curr Biol. 17:1298–1307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen J, Wang L, Matyunina LV, Hill CG and
McDonald JF: Overexpression of miR-429 induces
mesenchymal-to-epithelial transition (MET) in metastatic ovarian
cancer cells. Gynecol Oncol. 121:200–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bendoraite A, Knouf EC, Garg KS, Parkin
RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY,
Drescher CW, et al: Regulation of miR-200 family microRNAs and ZEB
transcription factors in ovarian cancer: Evidence supporting a
mesothelial-to-epithelial transition. Gynecol Oncol. 116:117–125.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tamura M, Watanabe M, Nakajima A, Kurai D,
Ishii H, Takata S, Nakamoto K, Sohara E, Honda K, Nakamura M, et
al: Serial quantification of procalcitonin (PCT) predicts clinical
outcome and prognosis in patients with community-acquired pneumonia
(CAP). J Infect Chemother. 20:97–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, et al: Genome-wide microRNA expression profiling in
renal cell carcinoma: Significant down-regulation of miR-141 and
miR-200c. J Pathol. 216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tamagawa S, Beder LB, Hotomi M, Gunduz M,
Yata K, Grenman R and Yamanaka N: Role of miR-200c/miR-141 in the
regulation of epithelial-mesenchymal transition and migration in
head and neck squamous cell carcinoma. Int J Mol Med. 33:879–886.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamamura S, Sharanjot S, Shahana M, Hirata
H, Ueno K, Chang I, Chiyomaru T, Tanaka Y and Dahiya R:
MicroRNA-141 inhibits proliferation and invasion by suppressing the
Wnt signaling pathway in renal cell carcinoma. Cancer Res.
72:31492012. View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong Z, Shi Y, Zhu Z, Li X, Ye Y, Zhang J,
Li A, Li G and Zhou J: JWA deficiency suppresses
dimethylbenz[a]anthracene-phorbol ester induced skin papillomas via
inactivation of MAPK pathway in mice. PLoS One. 7:e341542012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Savagner P: Leaving the neighborhood:
Molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perez-Pinera P, Alcantara S, Dimitrov T,
Vega JA and Deuel TF: Pleiotrophin disrupts calcium-dependent
homophilic cell-cell adhesion and initiates an
epithelial-mesenchymal transition. Proc Natl Acad Sci USA.
103:17795–17800. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Herreros AG, Peiró S, Nassour M and
Savagner P: Snail family regulation and epithelial mesenchymal
transitions in breast cancer progression. J Mammary Gland Biol
Neoplasia. 15:135–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang SY, Miah A, Pabari A and Winslet M:
Growth Factors and their receptors in cancer metastases. Front
Biosci (Landmark Ed). 16:531–538. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dave N, Guaita-Esteruelas S, Gutarra S,
Frias À, Beltran M, Peiró S and de Herreros AG: Functional
cooperation between Snail1 and twist in the regulation of ZEB1
expression during epithelial to mesenchymal transition. J Biol
Chem. 286:12024–12032. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kurahara H, Takao S, Maemura K, Mataki Y,
Kuwahata T, Maeda K, Ding Q, Sakoda M, Iino S, Ishigami S, et al:
Epithelial-mesenchymal transition and mesenchymal-epithelial
transition via regulation of ZEB-1 and ZEB-2 expression in
pancreatic cancer. J Surg Oncol. 105:655–661. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bianchi A, Gervasi ME and Bakin A: Role of
β5-integrin in epithelial-mesenchymal transition in response to
TGF-β. Cell Cycle. 9:1647–1659. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility, and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Neves R, Scheel C, Weinhold S, Honisch E,
Iwaniuk KM, Trompeter HI, Niederacher D, Wernet P, Santourlidis S
and Uhrberg M: Role of DNA methylation in miR-200c/141 cluster
silencing in invasive breast cancer cells. BMC research notes.
3:2192010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wellner U, Schubert J, Burk UC,
Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D,
Hausen AZ, et al: The EMT-activator ZEB1 promotes tumorigenicity by
repressing stemness-inhibiting microRNAs. Nat Cell Biol.
11:1487–1495. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu T, Zhao Y, Cao C, Hao R, Li C, Yi Y,
Gao S, Hui L and Liang A: Material and mechanisms induced pseudo
allergic reactions of Yuxingcao injection. Zhongguo Zhong Yao Za
Zhi. 35:1603–1606. 2010.(In Chinese). PubMed/NCBI
|
|
34
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoshino H, Enokida H, Itesako T, Tatarano
S, Kinoshita T, Fuse M, Kojima S, Nakagawa M and Seki N:
Epithelial-mesenchymal transition-related microRNA-200s regulate
molecular targets and pathways in renal cell carcinoma. J Hum
Genet. 58:508–516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Senanayake U, Das S, Vesely P, Alzoughbi
W, Fröhlich LF, Chowdhury P, Leuschner I, Hoefler G and Guertl B:
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated
and their common target ACVR2B is strongly expressed in renal
childhood neoplasms. Carcinogenesis. 33:1014–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Poell JB, van Haastert RJ, de Gunst T,
Schultz IJ, Gommans WM, Verheul M, Cerisoli F, van Noort PI,
Prevost GP, Schaapveld RQ and Cuppen E: A functional screen
identifies specific microRNAs capable of inhibiting human melanoma
cell viability. PLoS One. 7:e435692012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Jaarsveld MT, Helleman J, Boersma AW,
van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH,
Berns EM, Verweij J, et al: miR-141 regulates KEAP1 and modulates
cisplatin sensitivity in ovarian cancer cells. Oncogene.
32:4284–4293. 2013. View Article : Google Scholar : PubMed/NCBI
|
